IL1B and heart failure: NR treatment has been shown to reduce mitochondrial ROS production and inhibit the expression of proinflammatory factors, such as NLRP3 inflammatory vesicles and IL-1β and IL-18, as well as enhance mitochondrial respiration, which is beneficial for patients with heart failure [191,192].